Virtu Financial’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Virtu Financial’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,377	Closed	-$4K	–	2224
2023 Q2	$4K	Buy	20,377 +7,053	+53%	+$2.78K	﹤0.01%	1416
2023 Q1	$5K	Sell	13,324 -6,322	-32%	-$2.57K	﹤0.01%	1400
2022 Q4	$6K	Buy	+19,646	New	+$7.11K	﹤0.01%	1441
2021 Q2	–	Sell	-12,488	Closed	-$28K	–	2243
2021 Q1	$28K	Buy	+12,488	New	+$32.9K	﹤0.01%	1488
2020 Q4	–	Sell	-11,659	Closed	-$29K	–	1907
2020 Q3	$29K	Sell	11,659 -16,481	-59%	-$48K	0.01%	890
2020 Q2	$100K	Buy	+28,140	New	+$89K	0.01%	875
2019 Q4	$62K	Buy	+28,341	New	+$55.9K	0.01%	1171

Other funds holding NYMX

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

FCFC

First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

CAM

Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return

ODIJL

One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

Virtu Financial's NYMX Position: Q3 2023 in Review

Virtu Financial sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 20,377 shares — an estimated $4K sold.

Virtu Financial first reported a position in NYMX in Q4 2019 and held it in 7 quarters. The position peaked at $100K in Q2 2020. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

Virtu Financial reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
Virtu Financial sold 20,377 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $4K.
Virtu Financial first reported a position in Nymox Pharmaceutical Corp in Q4 2019 and held it in 7 quarters.
Virtu Financial's Nymox Pharmaceutical Corp position peaked at $100K in Q2 2020.
5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.